Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study

Oncology

Volumn 59, Issue 3, 2000, Pages 204-209

  Lencioni, Monica ^a,c   Falcone, Alfredo ^a   Allegrini, Giacomo ^a   Pfanner, Elisabetta ^a   Masi, Gianluca ^a   Brunetti, Isa ^a   Di Marsico, Roberta ^a   Fontana, Eloise ^a   Orlandini, Cinzia ^a   Stampino, Corrado Gallo ^b   Bartolozzi, Carlo ^a   Conte, Pier Franco ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ROCHE MILANO RICERCHE   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

Author keywords

Doxifluridine; Hepatocellular carcinoma; Oral chemotherapy; Phase II study

Indexed keywords

DOXIFLURIDINE;

ADULT; AGED; ANOREXIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH PAIN; STOMATITIS; TREATMENT OUTCOME; VOMITING;

EID: 0033764698     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012162     Document Type: Article

References (36)

1. Epidemiology of hepatocellular carcinoma
2. Primary hepatocellular carcinoma - Etiology, pathogenesis and prevention
3. Hepatocellular carcinoma in Chinese males and females, possible cause for the male predominance
4. Cancer mortality in Italy, 1994, and an overview of trends from 1955 to 1994
5. Cancer statistics, 1996
6. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States
7. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins
8. Hepatocellular carcinoma: A worldwide problem and the major risk factor
9. Hepatocellular carcinoma: Recent progress
10. Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: The experience of the National Cancer Institute of Milan
11. Current strategies for the treatment of hepatocellular carcinoma
12. Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long term results
13. Tamoxifen in treatment of hepatocellular carcinoma: A randomized controlled trial
14. Clinical trials in primary hepatocellular carcinoma: Current status and future directions
15. 5-Fluorouracil and leucovorin in hepatocellular carcinoma
16. Primary liver cancer
17. Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy
18. 4'Epidoxorubicin (epirubicin): Activity in heptatocellular carcinoma
19. High-dose mitomycin-C: Activity in hepatocellular carcinoma
20. Intraarterial and intravenous use of 4'epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison
21. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouracil in tumor-bearing mice and rats
22. Clinical trial of doxifluridine in the treatment of primary hepatocellular carcinoma
23. 5'-Deoxy-fluorouridine selective toxicity for human tumor cells compared to human bone marrow
24. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for improved therapeutic index
25. Fluorinated pyrimidine nucleosides. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides
26. Tumor inhibitory effects of a new fluorouracil derivative: 5'-Deoxy-5-fluorouridine
27. Phase II clinical evaluation of doxifluridine
28. Toxicite de la doxifluoridine, analogue peu myelosuppresseur du fluoro-uracile
29. Effect of uridine coadministration on 5'-deoxy-5-fluorouridine disposition in rats
30. Pharmacokinetic profile of doxifluridine, a fluorouracil pro-drug
31. Optimal two-stage design for phase II clinical trial
32. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
33. Oral doxifluridine in elderly patients with metastatic colorectal cancer: A multicenter phase II study
34. Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer
35. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients